يعرض 1 - 10 نتائج من 763 نتيجة بحث عن '"Glucagon-Like Peptide-1 Receptor"', وقت الاستعلام: 1.60s تنقيح النتائج
  1. 1
    دورية أكاديمية
    SPIRIT: Assessing Clinical Parameters Associated with Using IDegLira in Patients with Type 2 Diabetes in a Real-World Setting in Colombia.

    المؤلفون: Ramírez-Rincón, Alex1 (AUTHOR), Henao-Carrillo, Diana2 (AUTHOR), Omeara, Miguel3 (AUTHOR), Oliveros, Julio4 (AUTHOR), Assaf, José4 (AUTHOR), Ordóñez, Jaime E.5 (AUTHOR), Prasad, Preethy6 (AUTHOR), Alzate, María Alejandra7 (AUTHOR) ma.alzate20@gmail.com

    المصدر: Diabetes Therapy. Jul2024, Vol. 15 Issue 7, p1535-1545. 11p.

    مصطلحات موضوعية: *TYPE 2 diabetes, *GLUCAGON-like peptide-1 receptor, *GLYCEMIC control, *GLYCOSYLATED hemoglobin, *GLUCAGON-like peptide-1 agonists, *HYPERGLYCEMIA

    مصطلحات جغرافية: COLOMBIA

    النص الكامل

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Glucagon‐like peptide‐1 receptor agonists and risk of thyroid cancer: A systematic review and meta‐analysis of randomized controlled trials.

    المؤلفون: Silverii, Giovanni Antonio1 (AUTHOR) giovanniantonio.silverii@unifi.it, Monami, Matteo1 (AUTHOR), Gallo, Marco2 (AUTHOR), Ragni, Alberto2 (AUTHOR), Prattichizzo, Francesco3 (AUTHOR), Renzelli, Valerio4 (AUTHOR), Ceriello, Antonio3 (AUTHOR), Mannucci, Edoardo1 (AUTHOR)

    المصدر: Diabetes, Obesity & Metabolism. Mar2024, Vol. 26 Issue 3, p891-900. 10p.

    مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *GLUCAGON-like peptide-1 agonists, *THYROID cancer, *RANDOMIZED controlled trials, *SEQUENTIAL analysis, *DISEASE risk factors


    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Glucagon-like Peptide-1 Receptor Agonists Associated Gastrointestinal Adverse Events: A Cross-Sectional Analysis of the National Institutes of Health All of Us Cohort.

    المؤلفون: Aldhaleei, Wafa Ali1 (AUTHOR) aldhaleei.wafa@mayo.edu, Abegaz, Tadesse M.2 (AUTHOR) tadesse1.abegaz@famu.edu, Bhagavathula, Akshaya Srikanth3 (AUTHOR) akshaya.bhagavathula@ndsu.edu

    المصدر: Pharmaceuticals (14248247). Feb2024, Vol. 17 Issue 2, p199. 11p.

    مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *GLUCAGON-like peptide-1 agonists, *CROSS-sectional method, *SUMATRIPTAN

    الشركة/الكيان: NATIONAL Institutes of Health (U.S.)

    النص الكامل

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Effects of once‐weekly glucagon‐like peptide‐1 receptor agonists on type 2 diabetes mellitus complicated with coronary artery disease: Potential role of the renin‐angiotensin system.

    المؤلفون: Kan, Mengfan1 (AUTHOR), Fu, Hui2 (AUTHOR), Xu, Yunsheng3 (AUTHOR), Yue, Zhaodi4 (AUTHOR), Du, Bingyu4 (AUTHOR), Chen, Qiang4 (AUTHOR), Wang, Xueyin5 (AUTHOR), Yu, Shaohong6,7 (AUTHOR) sutcm2006@163.com, Zhang, Zhongwen5 (AUTHOR) zhangzhongwen@sdu.edu.cn

    المصدر: Diabetes, Obesity & Metabolism. Nov2023, Vol. 25 Issue 11, p3223-3234. 12p.

    مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *TYPE 2 diabetes, *GLUCAGON-like peptide-1 agonists, *CORONARY artery disease, *PEPTIDE receptors, *RENIN-angiotensin system, *LDL cholesterol


    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Dual metformin and glucagon-like peptide-1 receptor agonist therapy reduces mortality and hepatic complications in cirrhotic patients with diabetes mellitus.

    المؤلفون: Huynh, Daniel J.1, Renelus, Benjamin D.2, Jamorabo, Daniel S.3 daniel.jamorabo@stonybrookmedicine.edu

    المصدر: Annals of Gastroenterology. 2023, Vol. 36 Issue 5, p555-563. 21p.

    مصطلحات موضوعية: *GLUCAGON-like peptide-1 receptor, *GLUCAGON-like peptide-1 agonists, *ORAL medication, *DIABETES, *PEOPLE with diabetes, *HEPATIC veno-occlusive disease, *METFORMIN

    النص الكامل

    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Use of Tirzepatide in Adults with Type 2 Diabetes Mellitus: Scientific Evidence and Practical Aspects.

    المؤلفون: Vázquez, Luis A., Tofé-Povedano, Santiago, Bellido-Guerrero, Diego, Botella-Serrano, Marta, Soto-González, Alfonso, Mezquita-Raya, Pedro, Delgado, Elías, Fajardo-Montañana, Carmen, Morales-Portillo, Cristóbal, Causanilles, Ana, Rubio-de Santos, Miriam, Romera, Irene, Jódar-Gimeno, Esteban

    المصدر: Diabetes Therapy; Jul2024, Vol. 15 Issue 7, p1501-1512, 12p

    مصطلحات موضوعية: TYPE 2 diabetes, ENDOCRINOLOGISTS, GLUCAGON-like peptide-1 receptor, ADULTS

    النص الكامل

    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    Assessing the potential for precision medicine in body weight reduction with regard to type 2 diabetes mellitus therapies: A meta‐regression analysis of 120 randomized controlled trials.

    المؤلفون: Vargas, Kris G., Rütten, Tobias, Siemes, Benedikt, Brockmeyer, Maximilian, Parco, Claudio, Hoss, Alexander, Schlesinger, Sabrina, Jung, Christian, Roden, Michael, Kelm, Malte, Wolff, Georg, Kuss, Oliver

    المصدر: Diabetes, Obesity & Metabolism; Jun2024, Vol. 26 Issue 6, p2139-2146, 8p

    مصطلحات موضوعية: WEIGHT loss, TYPE 2 diabetes, INDIVIDUALIZED medicine, GLUCAGON-like peptide-1 receptor, GLUCAGON-like peptide-1 agonists


    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    Influence of early use of sodium-glucose transport protein 2 inhibitors, glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors on the legacy effect of hyperglycemia.

    المؤلفون: Siwei Deng, Houyu Zhao, Sanbao Chai, Yexiang Sun, Peng Shen, Hongbo Lin, Siyan Zhan

    المصدر: Frontiers in Endocrinology; 2024, p1-11, 11p

    مصطلحات موضوعية: GLUCAGON-like peptide-1 receptor, HYPERGLYCEMIA, GLUCAGON-like peptide-1 agonists, CD26 antigen, CARRIER proteins, SODIUM-glucose cotransporters, PROTEIN transport, PEPTIDE receptors

    النص الكامل

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    The impact of innovative glucose-lowering drugs on the course and outcome of COVID-19 in patients with type 2 diabetes mellitus

    المؤلفون: T. N. Markova, M. S. Stas

    المصدر: Сахарный диабет, Vol 27, Iss 2, Pp 174-184 (2024)

    مصطلحات موضوعية: covid-19, type 2 diabetes mellitus, metformin, glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors, dipeptidyl peptidase-4 inhibitors, Nutritional diseases. Deficiency diseases, RC620-627

    وصف الملف: electronic resource

    العلاقة: https://www.dia-endojournals.ru/jour/article/view/13106Test; https://doaj.org/toc/2072-0351Test; https://doaj.org/toc/2072-0378Test

    الوصول الحر: https://doaj.org/article/ae97781e6ea94104a58794a1475d9f60Test

    View record in DOAJ

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    Effect of glucagon-like peptide-1 receptor agonist on insulin secretion index and serum Wnt5a protein in patients with new-onset type 2 diabetes mellitus.

    المؤلفون: Xu, Wei1 (AUTHOR), Sang, Y. Q.1 (AUTHOR), Liu, X. K.1 (AUTHOR), Geng, H. F.1 (AUTHOR), Wang, Ben1 (AUTHOR), Shi, Li1 (AUTHOR), Qiu, Q. Q.1 (AUTHOR), Yu, T. P.1 (AUTHOR), Zhang, Yan2 (AUTHOR), Zhang, Xia2 (AUTHOR), Li, Lin3 (AUTHOR), Li, Qing2 (AUTHOR), Liang, Jun1 (AUTHOR) mwlj521@njmu.edu.cn

    المصدر: Journal of Diabetes & Metabolic Disorders. Jun2023, Vol. 22 Issue 1, p539-545. 7p.

    مصطلحات موضوعية: *PEPTIDE receptors, *GLUCAGON-like peptide-1 receptor, *GLUCAGON-like peptide-1 agonists, *BLOOD proteins, *TYPE 2 diabetes, *INSULIN receptors, *HOMEOSTASIS

    الشركة/الكيان: NOVO Nordisk A/S NVO, MERCK KGaA

    النص الكامل

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث